Mingxiao Li
Mingxiao Li
1
Department of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
1,
Xiaohui Ren
Xiaohui Ren
1
Department of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
1,
Gehong Dong
Gehong Dong
2
Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2,
Jincheng Wang
Jincheng Wang
3
Department of Radiology, Peking University Cancer Hospital, Beijing, China
3,
Haihui Jiang
Haihui Jiang
1
Department of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
1,
Chuanwei Yang
Chuanwei Yang
1
Department of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
1,
Xuzhe Zhao
Xuzhe Zhao
1
Department of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
1,
Qinghui Zhu
Qinghui Zhu
1
Department of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
1,
Yong Cui
Yong Cui
1
Department of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
1,
Kefu Yu
Kefu Yu
4
Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
4,
Song Lin
Song Lin
1
Department of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
5
Beijing Key Laboratory of Brain Tumor, Center of Brain Tumor, Institute for Brain Disorders, Beijing, China
6
Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
1,5,6,*
1
Department of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2
Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
3
Department of Radiology, Peking University Cancer Hospital, Beijing, China
4
Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
5
Beijing Key Laboratory of Brain Tumor, Center of Brain Tumor, Institute for Brain Disorders, Beijing, China
6
Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉*Correspondence: Song Lin, linsong2005@126.com
This article was submitted to Neuro-Oncology and Neurosurgical Oncology, a section of the journal Frontiers in Oncology
Received 2021 Apr 26; Accepted 2021 Apr 27; Collection date 2021.
Keywords: pseudoprogression, MGMT promoter methylation, subventricular zone, IDH wild-type, glioblastoma, random forest, nomogram
Copyright © 2021 Li, Ren, Dong, Wang, Jiang, Yang, Zhao, Zhu, Cui, Yu and Lin
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
